ICD-11 Codes
for 7A20.0 - Narcolepsy, Type 1

Teodor Jurukovski January 1, 1970

Fact checked by: Teodor Jurukovski

Use Code

Understanding Narcolepsy, Type 1 (ICD-11 Code 7A20.0)

Narcolepsy, Type 1, identified by the ICD-11 code 7A20.0, is a rare, chronic neurological disorder affecting the brain's ability to regulate sleep-wake cycles. This condition is primarily characterised by a deficiency in hypothalamic hypocretin (orexin) signalling. It leads to profound and uncontrollable daytime sleepiness, often accompanied by other distinct neurological symptoms. The ICD-11 code for Narcolepsy, Type 1 is 7A20.0, a critical identifier for medical documentation and billing purposes.

Key Symptoms of Narcolepsy, Type 1

The hallmark symptom of Narcolepsy, Type 1 is excessive daytime sleepiness (EDS), manifesting as an irrepressible need to sleep or sudden sleep attacks during wakefulness. A defining characteristic of this type is cataplexy, a sudden, transient loss of muscle tone that is typically triggered by strong emotions like laughter or surprise. Other common symptoms associated with Narcolepsy, Type 1 include:

• Sleep paralysis: A temporary inability to move or speak upon falling asleep or waking.
• Hypnagogic and hypnopompic hallucinations: Vivid, dream-like experiences occurring at the transition between wakefulness and sleep.
• Disrupted nocturnal sleep: Frequent awakenings during the night, despite excessive daytime drowsiness.

These symptoms significantly impact daily functioning, making it crucial for accurate coding for narcolepsy.

Exploring the Causes of Narcolepsy, Type 1

The exact cause of Narcolepsy, Type 1 is not fully understood, but it is strongly linked to a deficiency of hypocretin (orexin), a neuropeptide produced in the hypothalamus that regulates arousal and REM sleep. This deficiency is believed to result from the immune system mistakenly attacking the neurons that produce hypocretin. While the precise trigger for this autoimmune response remains unclear, potential contributing factors include genetic predispositions, such as the presence of the HLA-DQB1*0602 allele, and environmental factors like infections or hormonal changes. Understanding these factors is key for comprehensive documentation requirements.

Diagnosing Narcolepsy, Type 1

Diagnosing Narcolepsy, Type 1 involves a comprehensive evaluation. A definitive diagnosis typically requires the presence of daily periods of irrepressible sleepiness or sleep attacks, along with either cataplexy or demonstrated hypocretin deficiency in cerebrospinal fluid (CSF). Diagnostic methods may include:

• Multiple Sleep Latency Testing (MSLT): Measures how quickly a person falls asleep during the day. Characteristic findings include a mean sleep latency of less than 8 minutes and two or more sleep-onset REM periods (SOREMPs).
• Polysomnography (PSG): An overnight sleep study to monitor sleep patterns.
• Cerebrospinal Fluid (CSF) Analysis: Measuring hypocretin-1 levels, with levels below 110 picograms per milliliter often confirming the diagnosis.

Accurate diagnosis is essential for appropriate narcolepsy type 1 coding.

Management Strategies for Narcolepsy, Type 1

Currently, there is no cure for Narcolepsy, Type 1, as the loss of hypocretin-producing neurons is considered irreversible. Management focuses on alleviating symptoms and improving quality of life. Treatment approaches include:

• Lifestyle adjustments: Implementing a structured sleep schedule with scheduled short naps can help manage excessive daytime sleepiness. Maintaining good sleep hygiene is essential.
• Medications: Stimulants (e.g., modafinil, methylphenidate) to combat daytime sleepiness; anticataplectic drugs (e.g., certain antidepressants) to manage cataplexy; and sodium oxybate, which is effective for sleepiness, cataplexy, and disturbed nocturnal sleep. Pitolisant and solriamfetol are also used for managing sleepiness.

Effective management is key for patients seeking relief from the symptoms of this condition.

Synonyms and Alternative Terms for Narcolepsy, Type 1

Narcolepsy, Type 1 is known by several other clinical terms and synonyms, which are important for comprehensive medical documentation and patient understanding. These include:

• Narcolepsy with cataplexy
• Gelineau's syndrome
• Hypocretin deficiency syndrome
• Orexin deficiency syndrome

The ICD-11 code 7A20.0 specifically refers to Narcolepsy, Type 1, ensuring precise medical record-keeping.